Litigation Details for Hospira, Inc. v. Jiangsu Hengrui Medicine Co., Ltd. (D. Del. 2018)
✉ Email this page to a colleague
Hospira, Inc. v. Jiangsu Hengrui Medicine Co., Ltd. (D. Del. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-02-01 |
| Court | District Court, D. Delaware | Date Terminated | 2020-03-24 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 8,455,527; 8,648,106; 9,320,712; 9,616,049 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Hospira, Inc. v. Jiangsu Hengrui Medicine Co., Ltd.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Hospira, Inc. v. Jiangsu Hengrui Medicine Co., Ltd. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-01-31 | 1 | infringement of U.S. Patent Nos. 8,455,527 (the “ʼ527 patent”) (Ex. A); 8,648,106 (the “ʼ106 patent”) (Ex. B); … COUNT I FOR INFRINGEMENT OF PATENT NO. 8,455,527 23. Paragraphs 1 through… claims of the ʼ527 patent, the ʼ106 patent, the ʼ712 patent, and the ʼ049 patent are invalid and/or … “ʼ712 patent”) (Ex. C); and 9,616,049 (the “ʼ049 patent”) (Ex. D) (collectively, the “Patents-in-suit… THE PATENTS-IN-SUIT 10. The ʼ527 patent, entitled “Methods of Treatment | External link to document | |
| 2020-03-25 | 30 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,455,527 B1; US 8,648,106 …2018 24 March 2020 1:18-cv-00191 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
